| Literature DB >> 35953874 |
Timothy R Nurkiewicz1,2, Tammy A Butterick3,4,5,6, Janeen H Trembley7,8,9, Simon W So7,10, Joshua P Nixon7,11,12, Elizabeth C Bowdridge1,2, Krista L Garner1,2, Julie Griffith1,2, Kevin J Engles1,2, Thomas P Batchelor1,2, William T Goldsmith1,2, Julie M Tomáška12, Salik Hussain1,2.
Abstract
OBJECTIVE: Chronic multisymptom illness (CMI) is an idiopathic disease affecting thousands of U.S. Veterans exposed to open-air burn pits emitting aerosolized particulate matter (PM) while serving in Central and Southwest Asia and Africa. Exposure to burn pit PM can result in profound biologic consequences including chronic fatigue, impaired cognition, and respiratory diseases. Dysregulated or unresolved inflammation is a possible underlying mechanism for CMI onset. We describe a rat model of whole-body inhalation exposure using carbon black nanoparticles (CB) as a surrogate for military burn pit-related exposure. Using this model, we measured biomarkers of inflammation in multiple tissues.Entities:
Keywords: Burn Pit Exposure; Carbon Black; Chronic Multisymptom Illness; Cytokines; Environmental Exposure; Inflammation; Inhalation toxicology; Nanoparticle
Mesh:
Substances:
Year: 2022 PMID: 35953874 PMCID: PMC9373276 DOI: 10.1186/s13104-022-06165-2
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1CB nanoparticle characterization and deposition in lung. A CB particle characterization table and real-time mass concentration measurements (mg/m3) of the CB aerosols during an inhalation exposure for 6 h for a target concentration of 6 mg/m3. Data represent an average of three exposures. B Particle size distribution of the carbon black aerosol measured from the exposure chamber using a high resolution electrical low-pressure impactor (ELPI +). A log-normal fit of the distributions resulted in a count median diameter (CMD) of 67 nm with a geometric standard deviation (GSD) of 2.13 nm. Inset: representative image of CB particles. Scale bar 500 nm. C Particle size distribution of the CB aerosol measured from the exposure chamber with a cascade impactor (Nano-MOUDI). A log-normal fit of the distribution resulted in a mass median aerodynamic diameter of 975 nm with a GSD of 2.47 nm. D TEM and SEM images of CB agglomerate collected on a TEM grid from the exposure 6 mg/m3 chamber
Fig. 2Pro-inflammatory and vascular injury biomarker analysis in rat tissues. Changes in tissue biomarkers of inflammation between control (white bars) and CB6 (grey bars) exposed rats are shown for all 4 tissues; vascular injury biomarkers are shown for plasma. A Artery. B Brain. C Lung. D Plasma. Data are represented as means ± SEM. Significance is denoted as: * p < 0.05, ** p < 0.005, *** p < 0.0005, ****p < 0.0001; ns, not significant at threshold of p < 0.05
Pro-inflammatory and vascular injury biomarkers
| Analyte | Function |
|---|---|
| IL-1β | Cytokine: potent mediator of the inflammatory response; innate Th2 inflammatory response |
| IL-4 | Cytokine: innate Th2 inflammatory response |
| IL-5 | Cytokine: essential for eosinophil differentiation and survival; innate Th2 inflammatory response |
| IL-6 | Cytokine: pro-inflammatory roles; chronic inflammation |
| IL-10 | Cytokine: induced by inflammation, role in limiting immune response |
| IL-13 | Cytokine: innate Th2 inflammatory response |
| IFN-γ | Cytokine: important immunoregulatory functions; activator of macrophages |
| KC/GRO (CXCL1) | Chemokine: role in inflammation and as a chemoattractant for neutrophils |
| TNFα | Cytokine: innate Th2 inflammatory response |
| Adiponectin | Regulates glucose levels & fatty acid breakdown; positive association with cardiovascular mortality |
| MCP1 (CCL2) | Chemotactic for monocytes and basophils; associated with cardiovascular diseases and cognitive decline |
| sE-Selectin | Role in immunoadhesion; systemic endothelial dysfunction |
| sICAM-1 | Role in immunoadhesion; systemic endothelial dysfunction |
| TIMP1 | Regulator of extracellular matrix synthesis and degradation; biomarker of fibrosis |